Riley et al., Oncogene 2001
:
Using cells engineered with inducible p16 we showed that Cyclin D/CDK4/6 activity was required for v-Src to increase expression of cyclin A but not cyclin E
Matsumoto et al., Int Immunopharmacol 2005
:
Cyclin D2 expression by bupleuran 2IIc/PG-1 was inhibited by the tyrosine kinase inhibitors, genistein and herbimycin A, and the Src family tyrosine kinase inhibitor, PP2, suggesting a possible role for tyrosine kinases
Saxena et al., J Biol Chem 2007
(Breast Neoplasms...) :
We also show specific involvement of coactivator molecules, histone acetyltransferase SRC1 , and mediator complex in leptin mediated regulation of CYCLIN D1 promoter